Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04522245 · ClinicalTrials.gov registry record · NA
Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention
A NA study, sponsored by Noom.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04522245: Completed NA study, sponsored by Noom.
NCT04522245 is a NA study that has completed, run by Noom. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04522245, a NA study, has completed, sponsored by Noom.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The aim of this study is to compare brain changes in individuals with overweight or obesity enrolled in either the Noom Healthy Weight program or a matched control. The study objectives (primary and secondary) are to measure brain change reported as ERP and EEG data over a 16-week timeframe. Additionally, we will explore changes in the default mode network (resting-state asymmetry in EEG measurements), changes in executive functioning, quality of life, mood, and salivary markers as they relate to EEG data.
Primary Outcome
Change in amplitude and latency in conflict monitoring stage at 16 weeks
Interventions
- BEHAVIORAL Noom Healthy Weight; mobile behavior change program for weight loss.
- OTHER Matched Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-07-15 |
| Phase | NA |
What the finished NCT04522245 record still lists
NCT04522245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Noom Healthy Weight; mobile behavior change program for weight loss. is the first listed.
NCT04522245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04522245 about?
NCT04522245 is a clinical study titled "Evaluation of Brain Activity Changes After a Behavior Change Weight Loss Intervention". The aim of this study is to compare brain changes in individuals with overweight or obesity enrolled in either the Noom Healthy Weight program or a matched control. The study objectives (primary and secondary) are to measure brain change reported as ERP and EEG data over a 16-week timeframe. Additio...
What is the current status of trial NCT04522245?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-10-01. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT04522245?
The interventions under investigation include: Noom Healthy Weight; mobile behavior change program for weight loss. (BEHAVIORAL), Matched Control (OTHER).
Who is sponsoring clinical trial NCT04522245?
This trial is sponsored by Noom, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04522245's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI